DocGo Awarded Two Mobile Health and fitness Contracts in the Condition of Nevada

Foremost Cell Overall health Expert services and Transportation Innovator Awarded Contracts for Testing, Vaccination, and At-Property Infusion Therapies

NEW YORK, January 05, 2022–(Business WIRE)–DocGo Inc., a major company of last-mile cellular health products and services and integrated medical mobility solutions (Nasdaq:DCGO), declared the award of two new contracts to Ambulnz by DocGo in the state of Nevada. The mobile well being contracts involve COVID-19 screening, COVID-19 vaccine programs, and at-household monoclonal antibody infusion treatments to qualified people across the state of Nevada. These contracts were awarded to numerous businesses the mixed price of DocGo’s award is believed at $55 million about the upcoming 3 a long time.

DocGo delivers mobile overall health products and services at scale for clinic networks, governmental entities, and organization prospects. DocGo has done about 2 million COVID checks and administered more than 2 million COVID vaccines considering the fact that the start out of the pandemic, and not long ago commenced furnishing at house monoclonal antibody infusion treatment plans to clients in the comfort and ease and security of their own properties. In the coming weeks, skilled DocGo clinicians will be equipped to facilitate these companies throughout Nevada.

“Launching mobile wellness solutions in Nevada exemplifies our motivation to providing significant-top quality and inexpensive health care to a lot more people today,” mentioned Michael Costa, govt vice president of approach at DocGo. “We search ahead to offering these essential products and services to sufferers across the state.”

Monoclonal antibodies are laboratory-created proteins that mimic the immune system’s potential to fight off dangerous antigens this kind of as viruses. This intravenous treatment can deal with sufferers with gentle to average COVID-19 indicators, including these who haven’t been hospitalized or on oxygen because of to COVID, have a high hazard of establishing critical health conditions in hospitals, and have expert symptoms within just 10 times. Vaccinated clients are also eligible for monoclonal antibody therapy.

Story continues

In the coming months, DocGo designs to expand its monoclonal antibody infusion treatment plan to additional marketplaces throughout the US.

DocGo’s mobility options, enabled by means of remarkably…